AOD-9604 Research Guide
5mg · Research compound — not for human consumption
Research Overview
AOD-9604 is a synthetic peptide corresponding to the C-terminal fragment (residues 176-191) of human growth hormone. It was developed from work at Monash University aimed at isolating the lipid-metabolism-related portion of growth hormone, and has been studied in preclinical and clinical metabolic research. This is a research compound and is not intended for human consumption.
Structural & Class Overview
Short synthetic peptide fragment derived from the C-terminus of human growth hormone (hGH 176-191). Studied for lipid-metabolism-associated activity independent of the somatotrophic (IGF-1) and glucose effects of full-length growth hormone; not a receptor agonist of the incretin peptide class.
General Research Interest
Research interest includes adipocyte lipid-metabolism pathways in preclinical models, proposed interactions with beta-3 adrenergic signaling and hormone-sensitive lipase, separation of lipid-related activity from growth-hormone-mediated effects, and its historical clinical safety dataset.
Storage Considerations
Typically supplied as a lyophilized powder. General research handling keeps lyophilized material cold and protected from light and moisture; reconstituted solutions are generally refrigerated and used within a limited window. For laboratory research handling only.
Testing & Quality Considerations
Quality considerations include HPLC purity analysis, mass-spectrometry identity confirmation of the expected molecular mass, and verification against a batch Certificate of Analysis (COA) prior to use.
References
- AOD-9604 — PubChem CID 10270282
- Inhibition of growth hormone receptor and metabolic fragment research (PubChem record)
References are provided for scientific context. Linked sources are independent and not affiliated with iNGEN MD.
